» Articles » PMID: 11295385

Cognitive Therapy for Psychosis in Schizophrenia: an Effect Size Analysis

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2001 Apr 11
PMID 11295385
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

We conducted a meta-analysis using all available controlled treatment outcome studies of cognitive therapy (CT) for psychotic symptoms in schizophrenia. Effect sizes were calculated for seven studies involving 340 subjects. The mean effect size for reduction of psychotic symptoms was 0.65. The findings suggest that cognitive therapy is an effective treatment for patients with schizophrenia who have persistent psychotic symptoms. Follow-up analyses in four studies indicated that patients receiving CT continued to make gains over time (ES=0.93). Further research is needed to determine the replicability of standardized cognitive interventions, to evaluate the clinical significance of cognitive therapy for schizophrenia, and to determine which patients are most likely to benefit from this intervention.

Citing Articles

Gene Variant Related Neurological and Molecular Biomarkers Predict Psychosis Progression, with Potential for Monitoring and Prevention.

Fryar-Williams S, Tucker G, Clements P, Strobel J Int J Mol Sci. 2025; 25(24.

PMID: 39769114 PMC: 11677369. DOI: 10.3390/ijms252413348.


The Psychotherapy of Schizophrenia: A Review of the Evidence for Psychodynamic and Nonpsychodynamic Treatments.

Ruffalo M Psychiatry Clin Psychopharmacol. 2024; 33(3):222-228.

PMID: 38765312 PMC: 11082629. DOI: 10.5152/pcp.2023.23627.


Improving Romantic Relationship Functioning Among Young Men With First-Episode Psychosis: Impact of a Novel Group Intervention.

Cloutier B, Lecomte T, Diotte F, Lamontagne J, Abdel-Baki A, Daneault J Behav Modif. 2023; 47(5):1170-1192.

PMID: 37496322 PMC: 10403962. DOI: 10.1177/01454455231186586.


Feasibility and Effectiveness of a Psychosis-Specific Intensive Outpatient Program.

Samplin E, Grzenda A, Burns A Psychiatr Res Clin Pract. 2022; 4(3):74-79.

PMID: 36177441 PMC: 9477231. DOI: 10.1176/appi.prcp.20210030.


Importance of Non-pharmacological Approaches for Treating Irritable Bowel Syndrome: Mechanisms and Clinical Relevance.

Orock A, Yuan T, Greenwood-Van Meerveld B Front Pain Res (Lausanne). 2022; 1:609292.

PMID: 35295688 PMC: 8915633. DOI: 10.3389/fpain.2020.609292.